DCM is typically presented with a marked increase in low density lipoprotein (LDL), glucose, glycated hemoglobin (HbA1c) levels, fibrotic markers insulin-like growth factor (IGF)-B7 and transforming growth factor (TGF)-β1 levels, along with severe diastolic dysfunction [18]. This evidence concerns the gene TGFB1 and familial dilated cardiomyopathy.